Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

6505--Esomeprazole Magnesium Capsules Effective 10/19/2026 - 10/18/2027

Awarded
36E79726R0027Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This solicitation seeks commercial pharmaceutical supplies of Esomeprazole capsules under contract number VA-27-00001026, issued by the Department of Veterans Affairs through the National Acquisition Center in Hines, Illinois. The procurement is for seven line items covering multiple strengths and package sizes of Esomeprazole Magnesium and Esomeprazole capsules, with base year quantities ranging from 1,942 to 299,341 bottles per line item and identical quantities proposed for each of the four one-year option periods. All products must be FDA approved, manufactured in facilities maintaining current acceptable cGMP status, and carry a unique 11-digit National Drug Code (NDC) specific to the offeror. The contract is structured as a single award with pricing submitted for the base year and all four option years, incorporating a mandatory 0.5% Cost Recovery Fee embedded into all quoted prices. The evaluation will be conducted on a lowest-priced, technically acceptable basis without discussions, unless the Contracting Officer determines otherwise. Offerors must demonstrate compliance with all product specifications, including packaging requirements such as 120cc cylindrical bottles with safety or convertible caps, label dimensions of 5.25” x 2”, and sufficient space for VA-supplied labels and bar code visibility. All unit-of-use items must have bar codes in GS1-128, HIBC, or UPC format encoding the NDC, printed at ANSI/ISO/IEC Quality Grade C or better, with placement on both immediate and outer containers unless readable through packaging. The contract requires adherence to U.S. Pharmacopeia and FDA regulations, along with compliance with Healthcare Distribution Alliance guidelines. The contractor must maintain current and accurate registration in the System for Award Management, submit quarterly sales reports segmented by VA and Other Government Agencies, and report total Cost Recovery Fee collections. A subcontracting plan is required per VAAR 852.219-70 and applicable FAR clauses, with electronic reporting via eSRS. The contract includes clauses on ethics, whistleblower protections, subcontractor restrictions, and prohibitions on internal confidentiality agreements, with alternate I of FAR 52.203-6 applicable. Delivery is FOB Destination through Government Prime Vendor programs, with performance spanning a 60-day implementation period, a one-year base ordering period, and four one-year option periods. Proposals must be submitted electronically via email to designated VA contacts in Word or PDF format, with faxed or

General Info

VA seeks one supplier for Esomeprazole Capsules, one-year base plus four option years, electronic proposals.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

5

Amendment 0001 to RFP 36E79726R0027 - Proposal Due Date Extension

DOCX, High priority: read this firstamendment
High

Amendment 0002 to RFP 36E79726R0027 - Proposal Due Date Extension

DOCX, High priority: read this firstamendment
High

RFP 36E79726R0027 for Esomeprazole Capsules

DOCX, High priority: read this firstpresolicitation
High

Solicitation 36E79726R0027 for Esomeprazole Magnesium Capsules

DOCX, High priority: read this firstrfq
High

36E79726R0027 Award - Esomeprazole Magnesium Capsules

DOCX, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Deadline changed

Response deadline changed from Jul 6, 2026 to Jul 13, 2026.

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
James SullivanJames Sullivan

Full Description

Show more
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0027 for an unrestricted procurement for Esomeprazole Magnesium Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 &4, 30 count bottles; line items 2 & 5, 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0027 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 9, 2026, with a tentative closing date of June 23, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Sullivan. Questions can be e-mailed to contact@example.gov.








The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 ESOMEPRAZOLE 20MG CAP,EC 30 55,112 2 ESOMEPRAZOLE 20MG CAP,EC 90 21,059 3a ESOMEPRAZOLE 20MG CAP,EC 500 3,884 OR OR OR OR 3b ESOMEPRAZOLE 20MG CAP,EC 1000 1,942 4 ESOMEPRAZOLE 40MG EC CAP 30 299,341 5 ESOMEPRAZOLE 40MG EC CAP 90 22,995 6a ESOMEPRAZOLE 40MG EC CAP 500 11,208 OR OR OR OR 6b ESOMEPRAZOLE 40MG EC CAP 1000 5,604


Similar Contracts

Same NAICS industry code

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

7 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

13 days ago

DEADLINE

in 1 day
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS